Engineered skin bacteria induce antitumor T cell responses against melanoma
Open accessPublished version of a preprint
The DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
Abstract
Certain bacterial colonists induce a highly specific T cell response. A hallmark of this encounter is that adaptive immunity develops preemptively, in the absence of an infection. However, the functional properties of colonist-induced T cells are not well defined, limiting our ability to understand anticommensal immunity and harness it therapeutically. We addressed both challenges by engineering the skin bacterium Staphylococcus epidermidis to express tumor antigens anchored to secreted or cell-surface proteins. Upon colonization, engineered S. epidermidis elicits tumor-specific T cells that circulate, infiltrate local and metastatic lesions, and exert cytotoxic activity. Thus, the immune response to a skin colonist can promote cellular immunity at a distal site and can be redirected against a target of therapeutic interest by expressing a target-derived antigen in a commensal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Staphylococcus epidermidis can be genetically manipulated to express tumor antigens and to prevent or treat cancers expressing such antigens, including melanoma.178”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [178]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752
Car t cell immunotherapy for human cancer
June, C. H., O’Connor, R. S., Kawalekar, O. U., Ghassemi, S., & Milone, M. C. (2018) · Science · doi:10.1126/science.aar6711 · Cited by 3,207
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Twyman-Saint Victor, C., Rech, A. J., Maity, A., Rengan, R., Pauken, K. E., Stelekati, E., Benci, J. L., Xu, B., Dada, H., Odorizzi, P. M., et al. (2015) · Nature · doi:10.1038/nature14292 · Cited by 2,434
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Sakuishi, K., Apetoh, L., Sullivan, J. M., Blazar, B. R., Kuchroo, V. K., & Anderson, A. C. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100643 · Cited by 2,072
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Sade-Feldman, M., Yizhak, K., Bjorgaard, S. L., Ray, J. P., de Boer, C. G., Jenkins, R. W., Lieb, D. J., Chen, J. H., Frederick, D. T., Barzily-Rokni, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.038 · Cited by 2,053
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977
Research works printed but not linked: 1
- J. G. Swoboda “Wall teichoic acid biosynthesis as a novel antimicrobial target in Staphylococcus aureus ” thesis Harvard University (2009).
Cited by
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
Redenti, A., Im, J., Redenti, B., Li, F., Rouanne, M., Sheng, Z., Sun, W., Gurbatri, C. R., Huang, S., Komaranchath, M., et al. (2024) · Nature · doi:10.1038/s41586-024-08033-4 · Cited by 198
Gut microbiota shapes cancer immunotherapy responses
Lei, W., Zhou, K., Lei, Y., Li, Q., & Zhu, H. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00786-8 · Cited by 194
Role of the microbiota in response to and recovery from cancer therapy
Blake, S. J., Wolf, Y., Boursi, B., & Lynn, D. J. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00951-0 · Cited by 158
Design and regulation of engineered bacteria for environmental release
Chemla, Y., Sweeney, C. J., Wozniak, C. A., & Voigt, C. A. (2025) · Nature Microbiology · doi:10.1038/s41564-024-01918-0 · Cited by 142
The Multifaceted Role of Tissue-Resident Memory T Cells
Christo, S. N., Park, S. L., Mueller, S. N., & Mackay, L. K. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101320-020220 · Cited by 154
The gut microbiota in cancer immunity and immunotherapy
Xie, M., Li, X., Lau, H. C.-H., & Yu, J. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01326-2 · Cited by 138
Fan, Y., Ye, J., Kang, Y., Niu, G., Shi, J., Xue, Y., Li, R., Han, J., & Ji, X. (2024) · Science Advances · doi:10.1126/sciadv.adm9561 · Cited by 131
Bacterial therapies at the interface of synthetic biology and nanomedicine
Hahn, J., Ding, S., Im, J., Harimoto, T., Leong, K. W., & Danino, T. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00119-4 · Cited by 139
The human microbiome and cancer: a diagnostic and therapeutic perspective
Kandalai, S., Li, H., Zhang, N., Peng, H., & Zheng, Q. (2023) · Cancer Biology & Therapy · doi:10.1080/15384047.2023.2240084 · Cited by 101
Glioblastoma vaccines: past, present, and opportunities
Xiong, Z., Raphael, I., Olin, M., Okada, H., Li, X., & Kohanbash, G. (2024) · eBioMedicine · doi:10.1016/j.ebiom.2023.104963 · Cited by 90
Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments
Feldman, L. A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1384249 · Cited by 103
Lin, A., Xiong, M., Jiang, A., Huang, L., Wong, H. Z. H., Feng, S., Zhang, C., Yu, H., Chen, L., Chi, H., et al. (2025) · iMeta · doi:10.1002/imt2.70070 · Cited by 108
Engineered Living Materials for Advanced Diseases Therapy
Xue, D. Q., Wu, W. H., Pan, P., & Zhang, X. (2023) · Advanced Materials · doi:10.1002/adma.202304963 · Cited by 102
Melanoma and microbiota: Current understanding and future directions
Routy, B., Jackson, T., Mählmann, L., Baumgartner, C. K., Blaser, M., Byrd, A., Corvaia, N., Couts, K., Davar, D., Derosa, L., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2023.12.003 · Cited by 89
Mapping the T cell repertoire to a complex gut bacterial community
(2023) · doi:10.1038/s41586-023-06431-8 · Cited by 79
Self-citationThe Microbiome and Cancer: A Translational Science Review
Fernandez, E., Wargo, J. A., & Helmink, B. A. (2025) · JAMA · doi:10.1001/jama.2025.2191 · Cited by 95
Chen, Z., Yong, T., Wei, Z., Zhang, X., Li, X., Qin, J., Li, J., Hu, J., Yang, X., & Gan, L. (2023) · Advanced Science · doi:10.1002/advs.202305081 · Cited by 65
Yu, T., Xu, X., Liu, Y., Wang, X., Wu, S. X., Qiu, Z., Liu, X., Pan, X., Gu, C., Wang, S., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.06.002 · Cited by 63
Emerging clinical relevance of microbiome in cancer: promising biomarkers and therapeutic targets
Dai, J.-H., Tan, X.-R., Qiao, H., & Liu, N. (2023) · Protein & Cell · doi:10.1093/procel/pwad052 · Cited by 59
Discovery and engineering of the antibody response to a prominent skin commensal
Bousbaine, D., Bauman, K. D., Chen, Y. E., Lalgudi, P. V., Nguyen, T. T. D., Swenson, J. M., Yu, V. K., Tsang, E., Conlan, S., Li, D. B., et al. (2024) · Nature · doi:10.1038/s41586-024-08489-4 · Cited by 60
Self-citationMicrobiota in cancer: current understandings and future perspectives
Yao, Y., Zhu, Y., Chen, K., Chen, J., Li, Y., Li, D., & Wei, P. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02335-3 · Cited by 61
Microbe-material hybrids for therapeutic applications
Chen, M., Xia, L., Wu, C., Wang, Z., Ding, L. S., Xie, Y., Feng, W., & Chen, Y. (2024) · Chemical Society Reviews · doi:10.1039/d3cs00655g · Cited by 62
Self-citationZhu, B., Bai, Y., Yeo, Y. Y., Lu, X., Rovira‐Clavé, X., Chen, H. M., Yeung, J., Nkosi, D., Glickman, J. N., Delgado‐González, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56237-7 · Cited by 68
Skin microbiome and dermatologic disorders
Scharschmidt, T. C., & Segre, J. A. (2025) · Journal of Clinical Investigation · doi:10.1172/jci184315 · Cited by 62
The human skin microbiome: from metagenomes to therapeutics
Oh, J., & Voigt, A. Y. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01211-9 · Cited by 62
Engineered bacteria launch and control an oncolytic virus
Singer, Z. S., Pabón, J., Huang, H., Sun, W. Y., Luo, H., Grant, K. R., Obi, I., Coker, C., Rice, C. M., & Danino, T. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01476-8 · Cited by 57
Engineered Bacteria for Disease Diagnosis and Treatment Using Synthetic Biology
Jin, K., Huang, Y. B., Che, H., & Wu, Y. (2025) · Microbial Biotechnology · doi:10.1111/1751-7915.70080 · Cited by 59
Synthetic Biology‐Based Engineering Cells for Drug Delivery
Yi, W., Hu, S., Qian, X., Yan, W., & Li, Y. (2025) · Exploration · doi:10.1002/exp.20240095 · Cited by 67
De-coding the complex role of microbial metabolites in cancer
Escriva, P. P., Bernardino, C. C. T., & Letellier, E. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115358 · Cited by 54
Joglekar, P., Conlan, S., Lee-Lin, S.-Q., Deming, C., Kashaf, S. S., Program, N. C. S., Kong, H. H., Segre, J. A., Barnabas, B. B., Black, S., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2310585120 · Cited by 45
Engineering bacteria for cancer immunotherapy
Zalatan, J. G., Petrini, L. F. T., & Geiger, R. (2024) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2023.103061 · Cited by 44
Delivery of a sebum modulator by an engineered skin microbe in mice
Knödlseder, N., Fábrega, M.-J., Santos‐Moreno, J., Manils, J., Toloza, L., Vilar, M. M., Fernández, C., Broadbent, K., Maruotti, J., Leménager, H., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-02072-4 · Cited by 42
Macandog, A. D. G., Catozzi, C., Capone, M., Nabinejad, A., Nanaware, P. P., Liu, S., Vinjamuri, S., Stunnenberg, J. A., Galiè, S., Jodice, M. G., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.10.006 · Cited by 40
Engineered bacteria in tumor immunotherapy
Chen, H., Zhu, Y., Zhang, C., Hu, L. T., & Yang, K. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216817 · Cited by 44
Wang, H., Xu, F., Yao, C., Dai, H., Xu, J., Wu, B., Tian, B., Shi, X., & Wang, C. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2412070121 · Cited by 44
Engineering Strategies to Modulate the Gut Microbiome and Immune System
Han, K., Xu, J., Xie, F., Crowther, J., & Moon, J. J. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300480 · Cited by 43
Microbiota-induced T cell plasticity enables immune-mediated tumour control
Najar, T. A., Hao, Y., Hao, Y., Romero‐Meza, G., Dolynuk, A., Almo, E., & Littman, D. R. (2026) · Nature · doi:10.1038/s41586-025-09913-z · Cited by 39
Guillot, N., Roméo, B., Manesh, S. S., Milano, G., Brest, P., Zitvogel, L., Hofman, P., & Mograbi, B. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.08.004 · Cited by 36
Wei, X., Xue, B., Ruan, S., Guo, J., Huang, Y., Geng, X., Wang, D., Zhou, C., Zheng, J., & Yuan, Z. (2024) · Science Advances · doi:10.1126/sciadv.adk6331 · Cited by 37
Wang, L., Ji, P., Yu, J., Qiu, S., An, B., Huo, M., & Shi, J. (2024) · Science Advances · doi:10.1126/sciadv.adp7540 · Cited by 40
Engineered bacteria: Strategies and applications in cancer immunotherapy
Zhang, S., Li, R., Xu, Y., Liu, R., Sun, D., & Dai, Z. (2024) · Fundamental Research · doi:10.1016/j.fmre.2024.11.001 · Cited by 35
Commensal microbe regulation of skin cells in disease
Gan, Y., Zhang, J., Qi, F., Hu, Z., Sweren, E., Reddy, S., Chen, L., Feng, X., Grice, E. A., Garza, L. A., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.07.020 · Cited by 34
Designing live bacterial therapeutics for cancer
Lee, J., McClure, S., Weichselbaum, R. R., & Mimee, M. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115579 · Cited by 35
Zareie, P., Weiss, E. S., Kaplan, D. H., & Mackay, L. K. (2025) · Nature Immunology · doi:10.1038/s41590-025-02145-3 · Cited by 29
Immune cells in skin inflammation, wound healing, and skin cancer
Zhang, Y., & Lu, Q. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad107 · Cited by 31
Intratumoral Microbiome: Foe or Friend in Reshaping the Tumor Microenvironment Landscape?
Kyriazi, A. A., Karaglani, M., Agelaki, S., & Baritaki, S. (2024) · Cells · doi:10.3390/cells13151279 · Cited by 33
Xu, X., Ding, Y., Dong, Y., Yuan, H., Xia, P., Qu, C., Ma, J., Wang, H., Zhang, X., Zhao, L., et al. (2024) · Advanced Science · doi:10.1002/advs.202401905 · Cited by 33
Roots of synthetic ecology: microbes that foster plant resilience in the changing climate
Kozaeva, E., Eida, A. A., Gunady, E. F., Dangl, J. L., Conway, J. M., & Brophy, J. A. N. (2024) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2024.103172 · Cited by 27
Madaan, T., Doan, K., Hartman, A. R., Gherardini, D., Ventrola, A. J., Zhang, Y., & Kotagiri, N. (2024) · Experimental Dermatology · doi:10.1111/exd.70019 · Cited by 27
Recent advances of engineered probiotics for therapeutic applications
Zhang, L., Chen, N., Chen, H., Tang, C., Wang, J., Wang, Y., Zhang, Y., Guo, H., & Yuan, J. (2025) · BioDesign Research · doi:10.1016/j.bidere.2025.100039 · Cited by 32
The microbiome as a therapeutic co-driver in melanoma immuno-oncology
Bautista, J., Chávez, J. A. V., Larco, D. S. B., Martín-Aguilera, R., & López‐Cortés, A. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1673880 · Cited by 28
Gut Microbiota–Related Biomarkers in Immuno-Oncology
Silva, C. A. C., Fidelle, M., Almonte, A. A., Derosa, L., & Zitvogel, L. (2025) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061124-102218 · Cited by 22
Li, N., Yin, L., Wang, J., Zhang, J., & Tong, Y. (2025) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2025.103375 · Cited by 26
Yang, C., Saiding, Q., Chen, W., An, S., Zhao, S., Khan, M. M., Kong, N., Ge, M., Shi, J., Lin, H., et al. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01600-8 · Cited by 36
Roslan, M. A. M., Omar, M. N., Sharif, N. A. M., Raston, N. H. A., Arzmi, M. H., Neoh, H., & Ramzi, A. B. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00463-8 · Cited by 25
Zhang, Z., Wang, R., Mao, L., & Lu, M. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1613315 · Cited by 21
Wang, Y., Xiao, S., Yu, W., Han, B. R., & Guo, G. F. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01766-3 · Cited by 26
Aldriwesh, M. G., Alotibi, R. S., Alqurainy, N., Alrabiah, S., Arafah, A. M., Alghoribi, M. F., & Ajina, R. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2607076 · Cited by 24
Intratumoral microbiota: implications for cancer progression and treatment
Xie, Z., Wu, Z., Liu, Y., Gu, Y., Niu, J., & Lv, K. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1551515 · Cited by 23
A synthetic biology approach to engineering circuits in immune cells
Hoces, D., Blanco, J. M., & Hernández-López, R. A. (2023) · Immunological Reviews · doi:10.1111/imr.13244 · Cited by 20
Implantable living materials autonomously deliver therapeutics using contained engineered bacteria
Harimoto, T., Quevedo, F., Zillig, J., Schreiber, S., Wu, Y., Ahn, C. H., To, T., Thakur, R. A., Tatara, A. M., Kang, S., et al. (2026) · Science · doi:10.1126/science.aec2071 · Cited by 22
Could the tumor-associated microbiota be the new multi-faceted player in the tumor microenvironment?
Goubet, A. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1185163 · Cited by 19
Xia, W., Feng, Z., Wang, Y., Lei, R., Zhou, Y., Zhuo, Y., Xie, R., Dong, H., Zhao, X., Guan, X., et al. (2025) · ACS Nano · doi:10.1021/acsnano.4c13320 · Cited by 19
CD301b+ monocyte-derived dendritic cells mediate resistance to radiotherapy
Tadepalli, S., Clements, D. R., Raquer-McKay, H. M., Lüdtke, A., Saravanan, S., Seong, D., Vitek, L., Richards, C. M., Carette, J. E., Mack, M., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20231717 · Cited by 20
Pharmacomicrobiomics in precision cancer therapy: bench to bedside
Ngoc, K. L., Pham, T. T. H., Nguyen, T. K., & Huong, P. T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1428420 · Cited by 20
Staphylococcus epidermidis —key to understanding biofilms, commensalism, and more
Cheung, G. Y. C., & Otto, M. J. (2025) · Journal of Bacteriology · doi:10.1128/jb.00165-25 · Cited by 19
Engineering Bacteria as Living Therapeutics in Cancer Therapy
Chen, J., Chen, J., Chen, Y., Yuan, W., Zhang, J., Wang, G., & Dai, Z. (2025) · Advanced Science · doi:10.1002/advs.202507820 · Cited by 28
Self-citationDevelopment of Personalized Strategies for Precisely Battling Malignant Melanoma
Isaak, A. J., Clements, G. R., Buenaventura, R. G. M., Merlino, G. T., & Yu, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25095023 · Cited by 17
Engineered skin microbiome reduces mosquito attraction to mice
Liu, F., Coutinho-Abreu, I. V., Raban, R., Nguyen, T. T. D., Dimas, A., Merriman, J. A., & Akbari, O. S. (2024) · PNAS Nexus · doi:10.1093/pnasnexus/pgae267 · Cited by 17
Self-citationSetting “cold” tumors on fire: Cancer therapy with live tumor-targeting bacteria
Manole, S., Nguyen, D.-H., Min, J.-J., Zhou, S., & Forbes, N. (2024) · Med · doi:10.1016/j.medj.2024.11.002 · Cited by 20
Living Bacteria: A New Vehicle for Vaccine Delivery in Cancer Immunotherapy
Yang, M., Zhong, P., & Wei, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052056 · Cited by 18
Recent advances of engineered bacteria for therapeutic applications
Xiang, X., Zhou, Z., Rao, X., & Jiang, X. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.11.013 · Cited by 22
Impact of the Lung Microbiota on Development and Progression of Lung Cancer
Belaïd, A., Roméo, B., Rignol, G., Benzaquen, J., Audoin, T., Vouret‐Craviari, V., Brest, P., Varraso, R., von Bergen�, M., Marquette, C., et al. (2024) · Cancers · doi:10.3390/cancers16193342 · Cited by 18
Conserved genetic basis for microbial colonization of the gut
Liu, M., Blattman, S. B., Takahashi, M., Nandan, M. O., Jiang, W., Oikonomou, P., Tavazoie, S. F., & Tavazoie, S. (2025) · Cell · doi:10.1016/j.cell.2025.03.010 · Cited by 19
The multi-kingdom cancer microbiome
Dohlman, A. B., Pan, X., Zitvogel, L., & Iliev, I. D. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02103-7 · Cited by 18
Tissue-resident bacteria in metabolic diseases: emerging evidence and challenges
Massier, L., Musat, N., Stümvoll, M., Tremaroli, V., Chakaroun, R., & Kovacs, P. L. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01065-0 · Cited by 15
Chemical genetic approaches to dissect microbiota mechanisms in health and disease
Yang, X., & Hang, H. C. (2024) · Science · doi:10.1126/science.ado8548 · Cited by 16
Advances in Radionuclide-Labeled Biological Carriers for Tumor Imaging and Treatment
Yang, Y., Wang, J., Zhong, Y., Tian, M., & Zhang, H. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c19059 · Cited by 15
Ecological management of the microbiota in patients with cancer
Xavier, J. B. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01049-3 · Cited by 18
Targeting Intratumoral Bacteria for Cancer Treatment
Shi, J., Liang, J., Li, Y., Zhang, Z., Sun, J. X., He, Z., Luo, C., Qu, X., Che, X., & Zhang, S. (2025) · Small · doi:10.1002/smll.202505651 · Cited by 15
Wang, X., Shi, G., Zhu, X., Liu, Z., Liu, M., Wu, Z., He, Z., Li, K., Zhang, T., Liu, H., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c03960 · Cited by 13
Bacterial immunotherapy: is it a weapon in our arsenal in the fight against cancer?
Sharma, S., Sharma, H., & Gogoi, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1277677 · Cited by 15
Zhang, H., Chen, L., Chen, Q., Chen, Q., & Zhou, J. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202402272 · Cited by 11
Synthetically programmed antioxidant delivery by a domesticated skin commensal
Nevot, G., Santos‐Moreno, J., Sanz, N. C., Toloza, L., Parra-Cid, C., Jansen, P. A. M., Barbier, I., Ledesma‐Amaro, R., van den Bogaard, E. H. J., & Güell, M. (2025) · Cell Systems · doi:10.1016/j.cels.2025.101169 · Cited by 14
Qi, P., Gong, F., Leng, M., & Wei, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1674392 · Cited by 12
Nam, J., Lee, Y., Lee, S., Choi, H., Lee, S. Y., & Yang, D. (2025) · Biotechnology Advances · doi:10.1016/j.biotechadv.2025.108782 · Cited by 14
Cao, P., Li, Q., Li, Y., Guo, H., Wei, C., Xu, R., Ouyang, C., Chen, W., Wang, L., & Wang, Z. (2025) · Nature Communications · doi:10.1038/s41467-025-67437-6 · Cited by 12
Friends close, enemies closer: the complex role of the microbiome in antitumor immunity
Patra, D., Dev, G., Hand, T. W., & Overacre-Delgoffe, A. E. (2025) · Current Opinion in Immunology · doi:10.1016/j.coi.2025.102537 · Cited by 11
The epidermal immune microenvironment plays a central role in the pathogenesis of psoriasis
Zhou, Y., & Man, X. (2025) · Current Opinion in Immunology · doi:10.1016/j.coi.2025.102674 · Cited by 9
Genetically engineered plant endophytes broaden effector-triggered immunity
Hou, M., Zhu, S., Niu, R., Zhong, G., Wang, Z., Luo, M., Long, J., Yang, R., Tang, Z., Shi, S., et al. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2025.09.017 · Cited by 9
HBsAg-tagged tumour vaccine system eliminates solid tumours through virus-specific memory T cells
Wang, W., Chu, Y., Zhao, L., Lv, M., Wang, L., Jin, F., Hu, K., Cen, L., Qin, S., Li, X., et al. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01555-w · Cited by 10
Microbial medicines: Unlocking the therapeutic potential of the microbiome in cancer treatment
Canowitz, A., Kamble, N. H., Muck, N., Kaur, K., Garay, N., Bellala, P., Gabani, B. B., & Kotagiri, N. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114720 · Cited by 13
Engineered Bacterial Biomaterials for Augmenting Adoptive Immune Cell Therapy Against Solid Tumors
Zhu, C., Sun, Z., Wu, Q., Wang, F., Zhang, L. L., Wang, W., Ding, Y., & Li, H. (2026) · Advanced Materials · doi:10.1002/adma.202522140 · Cited by 11
Nanomaterial combined engineered bacteria for intelligent tumor immunotherapy
Qin, S., He, G., & Yang, J. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00741g · Cited by 11
Can Therapeutic Targeting of the Human Microbiome Influence Asthma Management? A Pro/Con Debate
Kau, A. L., Rosen, A. L., & Rosas‐Salazar, C. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.12.053 · Cited by 9
Bioengineered therapeutic systems for improving antitumor immunity
Cao, Y., Yan, W., Yi, W., Yin, Q., & Li, Y. (2024) · National Science Review · doi:10.1093/nsr/nwae404 · Cited by 10
Wang, L., Zhao, H. Y., Wu, F., Chen, J., Xu, H., Gong, W., Wen, S., Yang, M., Xia, J., Chen, Y., et al. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.03.030 · Cited by 8
Self-citationSkin microbiome engineering: Challenges and opportunities in skin diseases treatment
Lyu, Y., Shen, J., Che, Y., & Dai, L. (2025) · iMetaOmics. · doi:10.1002/imo2.70012 · Cited by 10
Vaccine therapies for glioma: clinical frontiers and potential breakthrough
Xing, Y., Liu, C., Feng, Y., Li, S., & Chen, Y. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1613332 · Cited by 11
Self-citationTumor Immunotherapy and Microbiome: From Bench‐to‐Bedside Applications
Lin, A., Xiong, M., Jiang, A., Chen, L., Huang, L., Li, K., Wong, H. Z. H., Zhang, J., Liu, Z., Cheng, Q., et al. (2026) · MedComm · doi:10.1002/mco2.70454 · Cited by 11
Metadata
- Authors
- Chen, Y. E., Bousbaine, D., Veinbachs, A., Atabakhsh, K., Dimas, A., Yu, V. K., Zhao, A., Enright, N. J., Nagashima, K., Belkaid, Y., & Fischbach, M. A.
- Affiliations
- San Francisco VA Medical Center (US)
- Stanford Medicine (US)
- National Institutes of Health (US)
- Corresponding author
- Fischbach, Michael A.
- ORCID
- Venue
- Science
- Published
- 2023-04-14
- Volume
- 380
- Issue
- 6641
- Pages
- 203-210
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC12356174
- OpenAlex
- W4365457270
- Cited by
- 191
- References
- 68
- Citations by year
- 2026: 40 · 2025: 80 · 2024: 48 · 2023: 23
- FWCI
- 20.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Science Foundation
- Howard Hughes Medical Institute
- Leona M. and Harry B. Helmsley Charitable Trust
- Harvard University
- Children's Discovery Institute (CDI-CORE-2019-813, CDI-CORE-2015-505)
- Open Philanthropy Project
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Astellas Pharma
- Astellas Foundation for Research on Metabolic Disorders
- National Institutes of Health (DK110174)
- Washington University School of Medicine in St. Louis (CDI-CORE-2015-505, CDI-CORE-2019-813)
- Center for Cellular Imaging, Washington University
- National Cancer Institute (P30CA124435)
- National Institute of Allergy and Infectious Diseases (ZIAAI001115, ZIAAI001132)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK110174)
- NHLBI Division of Intramural Research
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- Staphylococcus epidermidis, melanoma, antitumor T-cell responses, tumor-specific T cells, skin colonization, T cell cytotoxicity, metastatic melanoma, cancer immunotherapy
- MeSH terms
- Antigens, Neoplasm, Genetic Engineering, Humans, Immunity, Cellular, Melanoma, Skin, Skin Neoplasms, Staphylococcus epidermidis, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.